Pharmaceuticals & Biotech|Product Engineering

Recursion
Drug discovery

Physics simulations took weeks to screen libraries. Boltz-2 runs 1,000x faster, cutting this to hours with 2x precision.

PublishedDec 28, 2025|1 month ago

Key results

Processing Speed
1,000x
vs physics pipelines
Wet Lab Work Required
40%
Precision Improvement
2x
vs docking and prior ML approaches

Result highlights

Unlock 3 result highlights

The story

A clinical-stage biotechnology company manages 50 petabytes of biological and chemical data to industrialize the drug discovery process.

Traditional physics-based simulations required weeks to screen compound libraries, while earlier AI models could not accurately predict how strongly...

Unlock full story

The company

Recursion logo

Recursion

recursion.com

AI-driven drug discovery and clinical-stage biotechnology platform.

IndustryPharmaceuticals & Biotech
LocationSalt Lake City, UT, USA
Employees251-1K
Founded2013

Implementation partner

Massachusetts Institute of Technology logo

Massachusetts Institute of Technology

web.mit.edu

MIT researchers co-developed the Boltz-2 biomolecular foundation model with Recursion.

IndustryEducation & Training
LocationCambridge, MA, USA
Employees10K-50K
Founded1861

119 AI case studies in Pharmaceuticals & Biotech

1,341 AI case studies in Product Engineering